Pertinent risk factors and gastric carcinoma with synchronous peritoneal dissemination or liver metastasis
- PMID: 1948650
Pertinent risk factors and gastric carcinoma with synchronous peritoneal dissemination or liver metastasis
Abstract
From 1965 to 1985, of 1108 patients with advanced gastric cancer who underwent gastric resection in our department, 216 patients (19.5%) had synchronous peritoneal dissemination (PD) or liver metastasis (LM). The 1-year survival rate was 22.5% for PD, 14.7% for LM, and 4.8% for PD plus LM (p less than 0.01). With PD, patients were younger, tumor was larger, Borrmann type 3 and 4 and undifferentiated lesions were more frequent, and the incidence of serosal invasion was higher. Histologic findings showed a pattern of infiltrative growth. With LM, patients were more likely to be male, Borrmann type 2 and 3 and differentiated lesions were frequent, and the antral region was often involved. The degree of serosal invasion was less than with PD. The pattern of growth was the expansive type and vascular involvement was prominent. Rate of lymph node metastasis was high in both groups. The route of metastasis was partly linked to features of the primary lesion. Multivariate analysis showed that independent risk factors involved in the occurrence of each metastasis are serosal invasion, lymph node metastasis, and undifferentiated tissue type for PD, and lymph node metastasis and vascular involvement for LM. When designing treatment in an attempt to suppress a recurrence, even after curative resection, all of these risk factors must be kept in mind.
Similar articles
-
Lymphatic advancement to peritoneal dissemination and liver metastasis in gastric cancer patients.Anticancer Res. 1994 Nov-Dec;14(6B):2755-7. Anticancer Res. 1994. PMID: 7872713
-
[Clinicopathological analysis of synchronous liver metastasis in gastric cancer and evaluation of surgical outcomes].Zhonghua Wei Chang Wai Ke Za Zhi. 2006 Mar;9(2):127-30. Zhonghua Wei Chang Wai Ke Za Zhi. 2006. PMID: 16555151 Clinical Trial. Chinese.
-
Adenocarcinoma in the middle third of the stomach--an evaluation for the prognostic significance of clinicopathological features.Hepatogastroenterology. 1997 Sep-Oct;44(17):1488-94. Hepatogastroenterology. 1997. PMID: 9356878
-
Multivariate prognostic study on large gastric cancer.J Surg Oncol. 2007 Jul 1;96(1):14-8. doi: 10.1002/jso.20631. J Surg Oncol. 2007. PMID: 17582596 Review.
-
[CT and MR diagnosis of metastatic lesions in patients with gastric cancer].Nihon Rinsho. 2001 Apr;59 Suppl 4:193-8. Nihon Rinsho. 2001. PMID: 11424376 Review. Japanese. No abstract available.
Cited by
-
Prediction of distant metastasis and survival prediction of gastric cancer patients with metastasis to the liver, lung, bone, and brain: research based on the SEER database.Ann Transl Med. 2022 Jan;10(1):16. doi: 10.21037/atm-21-6295. Ann Transl Med. 2022. PMID: 35242861 Free PMC article.
-
Hepatectomy Offers Superior Survival Compared with Non-surgical Treatment for ≤ 3 Metastatic Tumors with Diameters < 3 cm from Gastric Cancer: A Retrospective Study.World J Surg. 2015 Nov;39(11):2757-63. doi: 10.1007/s00268-015-3151-0. World J Surg. 2015. PMID: 26148522
-
Chemokine receptors in cancer metastasis and cancer cell-derived chemokines in host immune response.Cancer Sci. 2007 Nov;98(11):1652-8. doi: 10.1111/j.1349-7006.2007.00606.x. Cancer Sci. 2007. PMID: 17894551 Free PMC article. Review.
-
Recurrences and related characteristics of gastric cancer.Br J Cancer. 1996 Sep;74(6):975-9. doi: 10.1038/bjc.1996.468. Br J Cancer. 1996. PMID: 8826869 Free PMC article.
-
Cytokeratin-positive cells in bone marrow for identifying distant micrometastasis of gastric cancer.Br J Cancer. 1996 Jan;73(1):83-7. doi: 10.1038/bjc.1996.15. Br J Cancer. 1996. PMID: 8554989 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Medical